You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Optimization of Iron Chelator Delivery System
SBC: GWATHMEY, INC. Topic: N/ALocation GWATHMEY, INC. 763 E CONCORD AVE CAMBRIDGE, MA 02138 United States 2R44HL068354-02A2 $3 900 210.00 2 008 Optimization of Iron Chelator Delivery System Department of Health and Human Services National Institutes of Health SBIR Y N Y PHS2007-2 GWAT ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Novel Catheter for Treatment of Ventricular Tachycardia
SBC: Thermedical Inc. Topic: N/ADESCRIPTION (provided by applicant): Ischemic ventricular tachycardia (VT) is a contributing cause to more than half of the 300,000 sudden cardiac deaths that occur annually in the United States. Implantable cardioverter defibrillators (ICDs) are the stand ard therapy but they are expensive the total cost of an ICD implant approaches 50,000 and the United States spends more than 2.2B on these im ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Cryopreservation and delivery of sporozoite vaccine
SBC: SANARIA INC. Topic: N/ADESCRIPTION (provided by applicant): Malaria causes 500 million clinical cases and gt 1 million deaths annually, is responsible for a loss of gt 1.3% of GDP in Africa annually, and is a serious concern for travelers and the military. A vaccine would be the ideal preventive and is perhaps the only intervention that could facilitate eradication of the disease. When attenuated P. falciparum sporozoi ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Image-Guided Stereotactic Radiosurgery of Breast Cancer
SBC: XCISION MEDICAL SYSTEMS, LLC Topic: N/ADESCRIPTION (provided by applicant): Breast cancer is the most prevalent malignancy among women. Its awareness and screening have resulted in the majority of breast cancers being diagnosed in the early-stage, for which breast conservation therapy (BCT) has become the standard of care. BCT consists of a lumpectomy followed by 6-8 weeks of radiation therapy, mostly irradiating whole breast. Althoug ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Development and Performance Evaluation of a Handheld Noninvasive Glucose Monitor
SBC: VIVASCAN CORPORATION Topic: N/ALocation 100 Grove Street Suite 315 Worcester, MA 01605 United States 2R44DK059088-04 $2 892 330.00 2 008 Development and Performance Evaluation of a Handheld Noninvasive Glucose Monitor Department of Health and Human Services National Institutes of Healt ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Robust Classification Methods for Categorical Regression
SBC: MARTINGALE RESEARCH CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Improving statistical methods to provide better classification performance and new analytical capabilities for categorical regression would be invaluable to the medical and health care research communities. Categorical regression models (e.g., binary logistic, multinomial logistic) are used extensively to identify patterns of alcohol-related symptoms, screen f ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Could Dedicated Breast PET Predict Multifocality?
SBC: NAVISCAN PET SYSTEMS, INC. Topic: N/ADESCRIPTION (provided by applicant): A two-phase study is planned to validate whether functional breast imaging with a dedicated breast PET device could detect and confirm breast cancer multifocality and/or multicentricity prior to surgery. Surgeons ar
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy
SBC: FASGEN, INC. Topic: N/ADESCRIPTION (provided by applicant): Phase I Ovarian cancer is the fifth leading cause of cancer death among U.S. women and has the highest mortality rate of all gynecologic cancers, with 23,400 new cases and 13,900 deaths projected in 2001. Screening
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Treatment of Sepsis with Talactoferrin
SBC: AGENNIX, INC. Topic: N/ADESCRIPTION (provided by applicant): Severe sepsis is a major cause of morbidity and mortality throughout the world. It is the leading cause of death in non-coronary intensive care units (ICUs) in the United States, with more than 750,000 cases occurring every year. This means that in the United States, more than 500 patients die from severe sepsis every day, with 28% to 50% of the patients succum ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Acetylator-based Individualized Dosing of Amonadife
SBC: XANTHUS LIFE SCIENCES, INC. Topic: N/AChemotherapeutic dosing has traditionally been empiric, with all patients receiving the same dose adjusted for body surface area (BSA). Unfortunately, while this may be adequate for the average person, it can be inappropriate for the majority of patien
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health